Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Audentes Therapeutics Inc (BOLD)

28.86 0.48 (1.69%)

12-14 16:00

Open:

28.46

Pre. Close:

28.38

High:

29.11

Low:

28.3053

Volume:

110,952

Market Cap:

862M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

29.11 - 31.67

31.67 - 31.67

Low:

28.31 - 28.36

28.36 - 28.36

Close:

28.86 - 31.4

31.4 - 31.4

Technical analysis  (as of: 2017-12-14 4:50:53 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 35.03     One year: 40.91

Support:

Support1: 26.60    Support2: 24.51

Resistance:

Resistance1: 29.99    Resistance2: 35.03

Pivot:

28.33

Moving Averages:

MA(5): 28.47     MA(20): 28.19

MA(100): 24.62     MA(250): 19.83

MACD:

MACD(12,26): 0.54     Signal(12,26,9): 0.58

%K %D:

%K(14,3): 49.76     %D(3): 50.20

RSI:

RSI(14): 58.35

52-Week:

High: 33.43  Low: 13.898  Change(%): 62.0

Average Vol(K):

3-Month: 29048  10-Days 16494

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BOLD has closed below upper band by 26.9%. Bollinger Bands are 50.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to BOLD's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 13 Dec 2017 12:56:15 GMT
Audentes Therapeutics Appoints Mark A. Goldberg, MD to its Board of Directors

Tue, 21 Nov 2017 13:07:30 GMT
Audentes Therapeutics Announces Publication of Data from RECENSUS, a ...

Wed, 27 Sep 2017 12:11:15 GMT
Audentes Therapeutics Announces Rare Pediatric Disease and Fast Track ...

Mon, 03 Apr 2017 12:13:33 GMT
Audentes Therapeutics Announces FDA Clearance of Investigational New Drug ...

Mon, 08 May 2017 12:11:15 GMT
Audentes Therapeutics Announces Appointment of John T. Gray, Ph.D. to Senior ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.86

Shares Float (M)

17.14

% Held by Insiders

3.00

% Held by Institutions

92.70

Shares Short (K)

782

Shares Short Prior Month (K)

713

Stock Financials

EPS

-3.480

EPS Est. Current Year

-3.500

EPS Est. Next Year

-3.630

EPS Est. Next Quarter

-0.900

Forward EPS

-3.660

Book Value (p.s.)

5.900

PEG Ratio

5.14

Profit Margin

Operating Margin

Return on Assets (ttm)

-30.0

Return on Equity (ttm)

-54.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.780

Qtrly Earnings Growth

Operating Cash Flow (M)

-73.65

Levered Free Cash Flow (M)

-48.74

atoplab.com

Valuation

P/E

-8.29

P/E Growth Ratio

0.02

P/BV

4.89

P/S

P/CF

-11.70

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.